KVUE · Full Picture

Kenvue Inc. — the full picture

Earnings window · 2026-07-16 to 2026-08-10 · anchored on the 10-Q report

One earnings window, everything merged: the filing, the call, press releases and news digests, folded into ranked threads.

What to look at first

  1. Segment Revenue Performance · Revenue growth & mixPriority 76
    +17.3% revenue (realized); 3 sources (news, press_release, sec_filing); structured_verified
    Fiscal six months Skin Health and Beauty Segment Net sales: $2,172 million, increase of $136 million, or 6.7%; excluding favorable FX of 2.3% Organic sales increased 4.4% (volume 2.6%, value realization 1.8%)
  2. Acquisition / Partnership / Divestiture · M&A and divestituresPriority 74
    3 sources (news, press_release, sec_filing); 3 forward row(s); quote_verified
    The transaction with Kimberly-Clark is expected to close in the fourth quarter of 2026, subject to receipt of foreign regulatory approvals and satisfaction of other customary closing conditions.
  3. Headcount / Restructuring · Restructuring & impairmentPriority 67
    -5.4% operating_income; 2 sources (news, press_release); 1 forward row(s); quote_verified
    The 2026 Restructuring Initiative is expected to result in pre-tax restructuring expenses and other charges totaling approximately $250 million in fiscal year 2026.
  4. Dividends · Buybacks & dividendsPriority 65
    2 sources (news, sec_filing); 2 forward row(s); quote_verified
    On July 29, 2026, we announced a 1.2% increase in the quarterly dividend as our Board declared a dividend of $0.21 per share payable on August 26, 2026 to shareholders of record as of the close of business on August 12, 2026.
  5. Kimberly-Clark Acquisition · M&A and divestituresPriority 60
    quote_verified
    Kenvue is undergoing a $40 billion buyout by Kimberly-Clark.
  6. Market Demand Trends · Demand, orders & backlogPriority 60
    3 sources (news, press_release, sec_filing); quote_verified
    Kenvue's second-quarter results showed 0.7% volume growth driving performance despite muted US and Europe performance, contributing to 3% revenue and 7% adjusted EPS growth per Morningstar.
  7. Liquidity and Debt Position · Debt, leverage & refinancingPriority 54
    -3.3% cash (realized); structured_verified
    Primary sources of liquidity include Cash and cash equivalents of $1,110 million as of June 28, 2026, borrowing capacity under a revolving credit facility of $4.0 billion which expires in March 2029, and authorized commercial paper program issuance of $4.0 billion.
  8. Segment Profitability · Operating income & profitabilityPriority 54
    +5.3% operating_income (realized); quote_verified
    Fiscal six months Skin Health and Beauty Segment adjusted operating income: $354 million, increased $113 million, or 46.9%
  9. Senior Notes Redemption · Debt, leverage & refinancingPriority 52
    -2.8% liability (realized); quote_verified
    On February 13, 2026, we issued a notice of full redemption to the holders of the 5.35% Senior Notes due 2026.
  10. Restructuring and Supply Chain Transformation · Restructuring & impairmentPriority 49
    -1.1% operating_income; 3 forward row(s); quote_verified
    The 2026 Restructuring Initiative is expected to result in pre-tax restructuring expenses and other charges totaling approximately $250 million in fiscal year 2026.
  11. Liquidity and Debt Position · Liquidity & cash positionPriority 48
    quote_verified
    Net debt was $(7.4) billion as of June 28, 2026 and $(7.5) billion as of December 28, 2025 (Cash and cash equivalents $1.1B, Total debt $(8.5)B).
  12. Operating Expense Trends · Operating expenses (SG&A)Priority 47
    quote_verified
    Selling, general, and administrative expenses for the fiscal six months ended June 28, 2026: $2,990 million, a decrease of $51 million, or 1.7%; SG&A as a percentage of Net sales decreased 210 basis points to 38.0% from 40.1%

Threads by pillar

Revenue & Demand Priority 87 · 6 threads

Costs & Margins Priority 87 · 8 threads

Capital & Balance Sheet Priority 81 · 6 threads

Strategy & Portfolio Priority 76 · 2 threads

Legal, Regulatory & Policy Priority 45 · 2 threads

Guidance & Outlook Priority 33 · 1 thread

Macro & Market Conditions Priority 36 · 3 threads

Expected impact by metric

metricforward netforward grossrealized
operating_income-6.7%+15.3%+5.3%
margin——+0.1%
cash——-3.6%
liability——-2.8%
net_income——-0.9%
revenue——+17.3%